Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lucía Vanrell"'
Autor:
Laura Rubio-Pérez, Susana Frago, Marta Compte, Rocío Navarro, Seandean L. Harwood, Rodrigo Lázaro-Gorines, Marina Gómez-Rosel, Oana Hangiu, Noelia Silva-Pilipich, Lucía Vanrell, Cristian Smerdou, Luis Álvarez-Vallina
Publikováno v:
Antibodies, Vol 13, Iss 2, p 34 (2024)
Immune checkpoint blockade has changed the treatment paradigm for advanced solid tumors, but the overall response rates are still limited. The combination of checkpoint blockade with anti-4-1BB antibodies to stimulate tumor-infiltrating T cells has s
Externí odkaz:
https://doaj.org/article/f4146a3dc0ce4049b9e43fa900b61edb
Publikováno v:
Microorganisms, Vol 9, Iss 9, p 1956 (2021)
Nanobodies are camelid-derived single-domain antibodies that present some advantages versus conventional antibodies, such as a smaller size, and higher tissue penetrability, stability, and hydrophilicity. Although nanobodies can be delivered as prote
Externí odkaz:
https://doaj.org/article/1731672cebab40f18133f92099d3321f
Autor:
Noelia Silva-Pilipich, Ester Blanco, Teresa Lozano, Eva Martisova, Ana Igea, Guillermo Herrador-Cañete, María Cristina Ballesteros-Briones, Marta Gorraiz, Patricia Sarrión, Gualberto González-Sapienza, Juan José Lasarte, Lucía Vanrell, Cristian Smerdou
Publikováno v:
Cancer Letters. 561:216139
Autor:
Noelia Silva-Pilipich, Eva Martisova, María Cristina Ballesteros-Briones, Sandra Hervas-Stubbs, Noelia Casares, Gualberto González-Sapienza, Cristian Smerdou, Lucia Vanrell
Publikováno v:
Biomedicines, Vol 8, Iss 12, p 562 (2020)
Immune checkpoint blockade using monoclonal antibodies (mAbs) able to block programmed death-1 (PD-1)/PD-L1 axis represents a promising treatment for cancer. However, it requires repetitive systemic administration of high mAbs doses, often leading to
Externí odkaz:
https://doaj.org/article/01cae54ccbae4c6ab01499d6b367397e
Autor:
Marianna Di Scala, Irene Gil-Fariña, Lucia Vanrell, Rodrigo Sánchez-Bayona, Diego Alignani, Cristina Olagüe, Africa Vales, Pedro Berraondo, Jesús Prieto, Gloria González-Aseguinolaza
Publikováno v:
Haematologica, Vol 100, Iss 8 (2015)
Interferon-α is a potent antiviral agent and a vigorous adjuvant in the induction of T-cell responses but its use is limited by hematologic toxicity. Interferon-α alters hematopoietic stem cell dormancy and impairs myelocytic and erythrocytic/megak
Externí odkaz:
https://doaj.org/article/eaf09cdc179d4707aaf0bfe80aa4377f
Autor:
Irene Gil-Fariña, Marianna Di Scala, Lucia Vanrell, Cristina Olagüe, Africa Vales, Katherine A High, Jesus Prieto, Federico Mingozzi, Gloria Gonzalez-Aseguinolaza
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e67748 (2013)
Recombinant adenoassociated viral vectors (rAAV) have proven to be excellent candidates for gene therapy clinical applications. Recent results showed that cellular immunity to AAV represents a major challenge facing the clinical use of systemic admin
Externí odkaz:
https://doaj.org/article/8562c53c30b54efe9a3d7c3eccf4532c